USANA Health Sciences (NYSE:USNA) disappointed in Q2 CY2024, missing revenue estimates and lowering full-year guidance. Despite challenges, the company maintains profitability. With a direct selling model, USANA offers health and wellness products, adapting to consumer trends like the "lipstick effect.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing